SMTL ID : 2msd.1

NMR data-driven model of GTPase KRas-GNP tethered to a lipid-bilayer nanodisc

Coordinates

PDB Format Compare

Method

SOLUTION NMR

Oligo State

hetero-2-1-mer

Ligands

64 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)

PCW.1: 8 residues within 4Å: Chain C: M.3 Ligands: PCW.5, PCW.26, 17F.35, 17F.36, 17F.38, 17F.40, PCW.68 Ligand excluded by PLIP PCW.2: 6 residues within 4Å: Chain A: A.155, H.158 Ligands: PCW.5, PCW.17, PCW.53, PCW.56 Ligand excluded by PLIP PCW.3: 5 residues within 4Å: Ligands: PCW.13, PCW.18, PCW.19, PCW.23, 17F.80 Ligand excluded by PLIP PCW.4: 5 residues within 4Å: Chain C: Q.45 Ligands: PCW.7, PCW.16, 17F.33, PCW.61 Ligand excluded by PLIP PCW.5: 7 residues within 4Å: Ligands: PCW.1, PCW.2, PCW.12, PCW.17, 17F.36, 17F.38, PCW.53 Ligand excluded by PLIP PCW.6: 13 residues within 4Å: Chain C: E.5, R.43, L.54, D.56 Ligands: PCW.7, PCW.9, PCW.11, PCW.16, PCW.24, PCW.25, PCW.28, 17F.39, PCW.60 Ligand excluded by PLIP PCW.7: 9 residues within 4Å: Chain C: T.4, Q.45, T.52 Ligands: PCW.4, PCW.6, PCW.16, 17F.33, PCW.41, PCW.61 Ligand excluded by PLIP PCW.8: 7 residues within 4Å: Chain A: Y.125 Chain B: K.55, Y.59 Chain C: K.186, C.187 Ligands: PCW.27, 17F.73 Ligand excluded by PLIP PCW.9: 11 residues within 4Å: Chain C: Q.72 Ligands: PCW.6, PCW.11, PCW.14, PCW.24, PCW.25, PCW.26, PCW.28, PCW.29, PCW.30, 17F.34 Ligand excluded by PLIP PCW.10: 9 residues within 4Å: Chain C: K.181, K.182, K.184 Ligands: PCW.12, PCW.21, PCW.22, 17F.36, 17F.37, PCW.46 Ligand excluded by PLIP PCW.11: 12 residues within 4Å: Chain C: E.39 Ligands: PCW.6, PCW.9, PCW.16, PCW.24, PCW.25, PCW.29, PCW.31, 17F.39, PCW.63, PCW.67, 17F.75 Ligand excluded by PLIP PCW.12: 7 residues within 4Å: Chain C: K.179 Ligands: PCW.5, PCW.10, PCW.22, PCW.30, 17F.36, 17F.37 Ligand excluded by PLIP PCW.13: 6 residues within 4Å: Ligands: PCW.3, PCW.14, PCW.18, PCW.30, 17F.34, 17F.37 Ligand excluded by PLIP PCW.14: 5 residues within 4Å: Chain C: Q.72 Ligands: PCW.9, PCW.13, PCW.23, 17F.34 Ligand excluded by PLIP PCW.15: 6 residues within 4Å: Chain A: L.19, L.34 Ligands: PCW.16, PCW.24, 17F.39, PCW.48 Ligand excluded by PLIP PCW.16: 8 residues within 4Å: Chain C: R.43 Ligands: PCW.4, PCW.6, PCW.7, PCW.11, PCW.15, PCW.24, 17F.39 Ligand excluded by PLIP PCW.17: 6 residues within 4Å: Chain C: S.173, K.174 Ligands: PCW.2, PCW.5, PCW.21, 17F.36 Ligand excluded by PLIP PCW.18: 6 residues within 4Å: Ligands: PCW.3, PCW.13, PCW.23, 17F.34, PCW.49, 17F.80 Ligand excluded by PLIP PCW.19: 3 residues within 4Å: Ligands: PCW.3, PCW.23, PCW.29 Ligand excluded by PLIP PCW.20: 2 residues within 4Å: Ligands: PCW.24, PCW.31 Ligand excluded by PLIP PCW.21: 4 residues within 4Å: Ligands: PCW.10, PCW.17, 17F.36, PCW.51 Ligand excluded by PLIP PCW.22: 10 residues within 4Å: Chain C: K.179, K.180, K.184, C.187 Ligands: PCW.10, PCW.12, PCW.30, 17F.36, 17F.37, PCW.51 Ligand excluded by PLIP PCW.23: 7 residues within 4Å: Ligands: PCW.3, PCW.14, PCW.18, PCW.19, PCW.29, 17F.34, 17F.79 Ligand excluded by PLIP PCW.24: 11 residues within 4Å: Chain C: E.39, S.41 Ligands: PCW.6, PCW.9, PCW.11, PCW.15, PCW.16, PCW.20, PCW.25, PCW.31, 17F.39 Ligand excluded by PLIP PCW.25: 9 residues within 4Å: Chain C: M.69 Ligands: PCW.6, PCW.9, PCW.11, PCW.24, PCW.29, PCW.31, PCW.60, PCW.72 Ligand excluded by PLIP PCW.26: 7 residues within 4Å: Chain C: M.3, T.76 Ligands: PCW.1, PCW.9, PCW.28, 17F.40, PCW.68 Ligand excluded by PLIP PCW.27: 5 residues within 4Å: Chain B: K.66 Ligands: PCW.8, 17F.37, PCW.47, 17F.76 Ligand excluded by PLIP PCW.28: 8 residues within 4Å: Chain C: M.3, E.5, K.7 Ligands: PCW.6, PCW.9, PCW.26, PCW.52, PCW.63 Ligand excluded by PLIP PCW.29: 7 residues within 4Å: Chain A: D.48 Chain B: Y.125 Ligands: PCW.9, PCW.11, PCW.19, PCW.23, PCW.25 Ligand excluded by PLIP PCW.30: 9 residues within 4Å: Chain C: D.107 Ligands: PCW.9, PCW.12, PCW.13, PCW.22, 17F.34, 17F.36, 17F.40, PCW.51 Ligand excluded by PLIP PCW.31: 5 residues within 4Å: Ligands: PCW.11, PCW.20, PCW.24, PCW.25, PCW.67 Ligand excluded by PLIP PCW.32: 2 residues within 4Å: Ligands: 17F.33, 17F.35 Ligand excluded by PLIP PCW.41: 6 residues within 4Å: Ligands: PCW.7, PCW.52, PCW.58, PCW.59, PCW.61, 17F.77 Ligand excluded by PLIP PCW.42: 5 residues within 4Å: Ligands: PCW.43, PCW.52, PCW.63, PCW.69, 17F.75 Ligand excluded by PLIP PCW.43: 7 residues within 4Å: Ligands: 17F.34, 17F.40, PCW.42, PCW.45, PCW.68, 17F.74, 17F.75 Ligand excluded by PLIP PCW.44: 7 residues within 4Å: Ligands: 17F.35, PCW.53, PCW.55, PCW.64, PCW.68, PCW.69, 17F.77 Ligand excluded by PLIP PCW.45: 5 residues within 4Å: Ligands: PCW.43, PCW.49, PCW.71, 17F.74, 17F.79 Ligand excluded by PLIP PCW.46: 4 residues within 4Å: Ligands: PCW.10, PCW.51, PCW.70, PCW.71 Ligand excluded by PLIP PCW.47: 6 residues within 4Å: Ligands: PCW.27, PCW.49, PCW.57, PCW.71, 17F.73, 17F.76 Ligand excluded by PLIP PCW.48: 4 residues within 4Å: Ligands: PCW.15, PCW.54, PCW.58, PCW.61 Ligand excluded by PLIP PCW.49: 8 residues within 4Å: Ligands: PCW.18, PCW.45, PCW.47, PCW.57, PCW.65, 17F.73, 17F.76, 17F.80 Ligand excluded by PLIP PCW.50: 1 residues within 4Å: Ligands: 17F.78 Ligand excluded by PLIP PCW.51: 8 residues within 4Å: Ligands: PCW.21, PCW.22, PCW.30, 17F.36, PCW.46, PCW.56, PCW.70, PCW.71 Ligand excluded by PLIP PCW.52: 5 residues within 4Å: Ligands: PCW.28, PCW.41, PCW.42, PCW.58, PCW.60 Ligand excluded by PLIP PCW.53: 8 residues within 4Å: Ligands: PCW.2, PCW.5, 17F.38, PCW.44, PCW.55, PCW.64, PCW.68, PCW.70 Ligand excluded by PLIP PCW.54: 4 residues within 4Å: Ligands: PCW.48, PCW.60, PCW.62, PCW.72 Ligand excluded by PLIP PCW.55: 5 residues within 4Å: Ligands: 17F.35, PCW.44, PCW.53, PCW.64, PCW.69 Ligand excluded by PLIP PCW.56: 4 residues within 4Å: Ligands: PCW.2, PCW.51, PCW.64, PCW.70 Ligand excluded by PLIP PCW.57: 4 residues within 4Å: Ligands: 17F.37, PCW.47, PCW.49, 17F.80 Ligand excluded by PLIP PCW.58: 4 residues within 4Å: Ligands: PCW.41, PCW.48, PCW.52, PCW.61 Ligand excluded by PLIP PCW.59: 3 residues within 4Å: Ligands: PCW.41, PCW.61, 17F.77 Ligand excluded by PLIP PCW.60: 7 residues within 4Å: Ligands: PCW.6, PCW.25, PCW.52, PCW.54, PCW.61, PCW.62, PCW.63 Ligand excluded by PLIP PCW.61: 7 residues within 4Å: Ligands: PCW.4, PCW.7, PCW.41, PCW.48, PCW.58, PCW.59, PCW.60 Ligand excluded by PLIP PCW.62: 6 residues within 4Å: Ligands: 17F.39, PCW.54, PCW.60, PCW.67, PCW.72, 17F.78 Ligand excluded by PLIP PCW.63: 7 residues within 4Å: Ligands: PCW.11, PCW.28, PCW.42, PCW.60, PCW.67, PCW.72, 17F.75 Ligand excluded by PLIP PCW.64: 6 residues within 4Å: Ligands: 17F.35, 17F.38, PCW.44, PCW.53, PCW.55, PCW.56 Ligand excluded by PLIP PCW.65: 3 residues within 4Å: Ligands: PCW.49, PCW.66, 17F.80 Ligand excluded by PLIP PCW.66: 5 residues within 4Å: Ligands: PCW.65, PCW.67, 17F.78, 17F.79, 17F.80 Ligand excluded by PLIP PCW.67: 9 residues within 4Å: Ligands: PCW.11, PCW.31, PCW.62, PCW.63, PCW.66, PCW.69, PCW.72, 17F.74, 17F.75 Ligand excluded by PLIP PCW.68: 7 residues within 4Å: Ligands: PCW.1, PCW.26, PCW.43, PCW.44, PCW.53, PCW.69, PCW.70 Ligand excluded by PLIP PCW.69: 6 residues within 4Å: Ligands: 17F.35, PCW.42, PCW.44, PCW.55, PCW.67, PCW.68 Ligand excluded by PLIP PCW.70: 6 residues within 4Å: Ligands: PCW.46, PCW.51, PCW.53, PCW.56, PCW.68, PCW.71 Ligand excluded by PLIP PCW.71: 5 residues within 4Å: Ligands: PCW.45, PCW.46, PCW.47, PCW.51, PCW.70 Ligand excluded by PLIP PCW.72: 5 residues within 4Å: Ligands: PCW.25, PCW.54, PCW.62, PCW.63, PCW.67 Ligand excluded by PLIP

16 x 17F: O-[(S)-({(2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl}oxy)(hydroxy)phosphoryl]-L-serine(Non-functional Binders)(Non-covalent)

17F.33: 3 residues within 4Å: Ligands: PCW.4, PCW.7, PCW.32 No protein-ligand interaction detected (PLIP) 17F.34: 8 residues within 4Å: Ligands: PCW.9, PCW.13, PCW.14, PCW.18, PCW.23, PCW.30, 17F.40, PCW.43 No protein-ligand interaction detected (PLIP) 17F.35: 7 residues within 4Å: Ligands: PCW.1, PCW.32, 17F.38, PCW.44, PCW.55, PCW.64, PCW.69 No protein-ligand interaction detected (PLIP) 17F.36: 10 residues within 4Å: Chain C: K.181 Ligands: PCW.1, PCW.5, PCW.10, PCW.12, PCW.17, PCW.21, PCW.22, PCW.30, PCW.51 2 PLIP interactions: 2 interactions with chain C Hydrogen bonds: C:K.181 Salt bridges: C:K.181 17F.37: 8 residues within 4Å: Chain C: K.179, K.180 Ligands: PCW.10, PCW.12, PCW.13, PCW.22, PCW.27, PCW.57 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:K.179, C:K.180 Salt bridges: C:K.179 17F.38: 5 residues within 4Å: Ligands: PCW.1, PCW.5, 17F.35, PCW.53, PCW.64 No protein-ligand interaction detected (PLIP) 17F.39: 7 residues within 4Å: Chain C: R.43 Ligands: PCW.6, PCW.11, PCW.15, PCW.16, PCW.24, PCW.62 1 PLIP interactions: 1 interactions with chain C Salt bridges: C:R.43 17F.40: 8 residues within 4Å: Chain C: M.172, G.176, K.177 Ligands: PCW.1, PCW.26, PCW.30, 17F.34, PCW.43 4 PLIP interactions: 4 interactions with chain C Hydrogen bonds: C:K.177, C:K.177 Salt bridges: C:K.177, C:K.177 17F.73: 4 residues within 4Å: Ligands: PCW.8, PCW.47, PCW.49, 17F.76 No protein-ligand interaction detected (PLIP) 17F.74: 5 residues within 4Å: Ligands: PCW.43, PCW.45, PCW.67, 17F.75, 17F.79 No protein-ligand interaction detected (PLIP) 17F.75: 7 residues within 4Å: Ligands: PCW.11, PCW.42, PCW.43, PCW.63, PCW.67, 17F.74, 17F.79 No protein-ligand interaction detected (PLIP) 17F.76: 4 residues within 4Å: Ligands: PCW.27, PCW.47, PCW.49, 17F.73 No protein-ligand interaction detected (PLIP) 17F.77: 5 residues within 4Å: Chain B: T.196, L.199 Ligands: PCW.41, PCW.44, PCW.59 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:L.199 17F.78: 3 residues within 4Å: Ligands: PCW.50, PCW.62, PCW.66 No protein-ligand interaction detected (PLIP) 17F.79: 6 residues within 4Å: Ligands: PCW.23, PCW.45, PCW.66, 17F.74, 17F.75, 17F.80 No protein-ligand interaction detected (PLIP) 17F.80: 7 residues within 4Å: Ligands: PCW.3, PCW.18, PCW.49, PCW.57, PCW.65, PCW.66, 17F.79 No protein-ligand interaction detected (PLIP)

1 x GNP: PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER(Non-covalent)

GNP.81: 20 residues within 4Å: Chain C: G.14, G.15, V.16, G.17, K.18, S.19, A.20, F.30, V.31, D.32, E.33, Y.34, D.35, P.36, T.37, N.118, K.119, S.147, A.148, K.149 14 PLIP interactions: 14 interactions with chain C Hydrogen bonds: C:G.17, C:K.18, C:S.19, C:S.19, C:A.20, C:D.32, C:Y.34, C:T.37, C:N.118, C:A.148, C:K.149 Salt bridges: C:D.121 pi-Stacking: C:F.30 pi-Cation interactions: C:K.119

1 x MG: MAGNESIUM ION(Non-covalent)

MG.82: 4 residues within 4Å: Chain C: S.19, T.37, D.40, D.59 4 PLIP interactions: 4 interactions with chain C Metal complexes: C:T.37, C:D.40, C:D.40, C:D.59

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mazhab-Jafari, M.T. et al., Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site. Proc.Natl.Acad.Sci.USA (2015)

Release Date

2015-06-03

Peptides

Apolipoprotein A-I: AB
GTPase KRas: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

C
B

Apolipoprotein A-I

GTPase KRas

Related Entries With Identical Sequence